Trial Profile
FGF23 response in hypophosphatemia
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2016
Price :
$35
*
At a glance
- Drugs Lanthanum carbonate (Primary)
- Indications Hypophosphataemia
- Focus Therapeutic Use
- 27 Sep 2016 New trial record